The effects of pharmaceutical excipients on drug disposition

Advanced Drug Delivery Reviews
Talia R BugginsGlyn Taylor

Abstract

Many new chemical entities are poorly soluble, requiring the use of co-solvents or excipients to produce suitable intravenous formulations for early pre-clinical development studies. There is some evidence in the literature that these formulation components can have significant physiological and physicochemical effects which may alter the distribution and elimination of co-administered drugs. Such effects have the potential to influence the results of pre-clinical pharmacokinetic studies, giving a false impression of a compound's intrinsic pharmacokinetics and frustrating attempts to predict the drug's ultimate clinical pharmacokinetics. This review describes the reported effects of commonly used co-solvents and excipients on drug pharmacokinetics and on physiological systems which are likely to influence drug disposition. Such information will be useful in study design and evaluating data from pharmacokinetic experiments, so that the potential influence of formulation components can be minimised.

References

Mar 1, 1991·Journal of Pharmaceutical Sciences·D J Gole, J B Nagwekar
Jan 1, 1990·General Pharmacology·T T OshiroS Oga
Oct 1, 1986·Antimicrobial Agents and Chemotherapy·P C Iwen, N G Miller
Dec 15, 1967·Science·J J Brink, D G Stein
Jan 15, 1980·Experientia·E Rubinstein, A Lev-El
Jul 1, 1995·The International Journal of Biochemistry & Cell Biology·K WoodburnD Kessel
Mar 1, 1993·Transplant International : Official Journal of the European Society for Organ Transplantation·A TibellA Alvestrand
Jan 1, 1996·Cancer Chemotherapy and Pharmacology·A G EllisL K Webster
Sep 1, 1996·Pharmacology & Toxicology·T A AasmundstadJ Mørland
Aug 1, 1997·Journal of Pharmaceutical Sciences·S DuttaW F Ebling
Dec 9, 1997·Anesthesia and Analgesia·A W DoenickeJ Babl
Mar 21, 1998·The Journal of Pharmacy and Pharmacology·S Dutta, W F Ebling
Jan 29, 1999·Cancer Chemotherapy and Pharmacology·A G Ellis, L K Webster
Jun 11, 1999·International Journal of Pharmaceutics·K M ParkC K Kim
Sep 29, 2000·Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine·R Bettschart-WolfensbergerK W Clarke
Mar 29, 2001·The Journal of Pharmacy and Pharmacology·D DimitrijevicA T Florence
Jun 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·S C KimM H Seo
Jun 8, 2001·Human & Experimental Toxicology·B H Ali, H M Mousa
Feb 28, 2002·Cancer Chemotherapy and Pharmacology·Heleen A BardelmeijerOlaf van Tellingen
Jun 6, 2002·British Journal of Clinical Pharmacology·Meret Martin-FacklamWalter E Haefeli

❮ Previous
Next ❯

Citations

May 23, 2012·Pharmaceutical Research·Ravikiran Panakanti, Ajit S Narang
Jul 27, 2010·AAPS PharmSciTech·Sergey V KurkovDonna Madden
Jul 1, 2010·Therapeutic Delivery·David J Brayden, Sam Maher
Dec 12, 2012·Advanced Drug Delivery Reviews·Lin MeiSi-Shen Feng
Oct 12, 2010·Molecular Membrane Biology·Srinivas GantaMansoor Amiji
Apr 6, 2011·Expert Opinion on Drug Delivery·Maite AgüerosJuan M Irache
Oct 1, 2013·Expert Opinion on Drug Metabolism & Toxicology·Evan A Thackaberry
Jun 1, 2014·Expert Opinion on Drug Metabolism & Toxicology·Diane E T BastiaansDavid M Burger
Feb 7, 2016·Fitoterapia·Chang-Shun LiuXiao-Ying Long
Oct 4, 2012·Journal of Pharmaceutical Sciences·Sergey V KurkovThorsteinn Loftsson
Oct 27, 2012·Journal of Colloid and Interface Science·Sergio MurgiaGerardo Palazzo
Jun 19, 2010·Journal of Chromatography. a·Julia KuligowskiMiguel de la Guardia
Mar 11, 2010·International Journal of Pharmaceutics·Emad B BasaliousShaimaa M Badr-Eldin
Dec 25, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·David P ElderRené Holm
Sep 22, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Oliver KummerStephan Krähenbühl
Aug 28, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yong-Mei YinDae-Duk Kim
Jul 8, 2008·International Journal of Pharmaceutics·Emma L McConnellAbdul W Basit
Nov 3, 2010·The Journal of Pharmacy and Pharmacology·Thorsteinn Loftsson, Marcus E Brewster
Apr 20, 2016·Advanced Drug Delivery Reviews·Orlagh M FeeneyChristopher J H Porter
Jun 11, 2015·The Journal of Pharmacy and Pharmacology·Thorsteinn LoftssonAngel Concheiro
Jan 10, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Shyam S BansalRamesh C Gupta
Jul 8, 2014·Pharmaceutical Patent Analyst·Sam MaherDavid J Brayden
Oct 27, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Bo LiuTove Tuntland
Jul 20, 2012·Molecular Pharmaceutics·Anett EngelMarkus Keiser
May 25, 2013·Molecular Pharmaceutics·Philip MartinAndrew Owen
Aug 3, 2011·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Gunjeet KaurAmit K Goyal
Feb 7, 2013·Pharmacological Reviews·Hywel D WilliamsChristopher J H Porter
Aug 18, 2017·Critical Reviews in Toxicology·Melissa A DavidsonDaniel Krewski
Mar 1, 2016·Cannabis and Cannabinoid Research·István Ujváry, Lumír Hanuš
Feb 7, 2020·Current Pharmaceutical Design· HarshitaZiyaur Rahman
Feb 14, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Katarzyna SzymczykJoanna Krawczyk
Aug 14, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Yi-Zhong GuFrank D Sistare
Sep 20, 2020·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Ludovic Le HegaratSandrine Charles
Feb 29, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Cordula StillhartAnette Müllertz
Jun 23, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jelena R MitrovićSnežana D Savić
Apr 22, 2018·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Rea D SignorellJean-Christophe Leroux
Jul 1, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Min-Jeong KimRobert B Innis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Martin KuentzDieter Röthlisberger
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Gøril Eide FlatenMartin Brandl
Il Farmaco
Giorgio Pifferi, Patrizia Restani
© 2021 Meta ULC. All rights reserved